Table 6.
Influence of LUT-SNEDDS (LSN1) and LUT suspension administrations on different biomarkers of rat serum.
| Groups | AST (U/L) | ALT (U/L) | ALP (U/L) | γ-GGT (U/L) | Bilirubin (U/L) |
|---|---|---|---|---|---|
| I | 76.48 ± 1.89 | 34.69 ± 0.96 | 99.58 ± 2.65 | 1.50 ± 0.06 | 0.75 ± 0.02 |
| II | 224.41 ± 5.89 | 96.61 ± 1.96 | 227.45 ± 6.14 | 3.74 ± 0.12 | 1.10 ± 0.03 |
| III | 95.21 ± 0.98 | 45.24 ± 1.78 | 110.58 ± 1.95 | 1.97 ± 0.02 | 0.73 ± 0.02 |
| IV | 175.28 ± 4.57 | 68.29 ± 1.89 | 158.68 ± 3.59 | 2.58 ± 0.05 | 0.90 ± 0.04 |
| V | 102.24 ± 2.64 | 51.28 ± 1.38 | 112.12 ± 2.52 | 1.89 ± 0.07 | 0.70 ± 0.01 |
| Normal levels | 75.80 ± 1.04 | 33.94 ± 0.98 | 81.09 ± 1.80 | 1.26 ± 0.06 | 0.72 ± 0.01 |